Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for ...
Even standard polymerase chain reaction (PCR) technology should, in principle, boost weak mutant signals so that they may emerge from all the genomic noise emitted by wild-type sequences. Yet standard ...
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years, digital PCR (dPCR) has captured the attention of researchers and clinicians ...
Early molecular response in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with dasatinib (DAS) or imatinib (IM) from DASISION. Survival outcomes of sustained MR4.5 in ...
Across all areas of life sciences research, scientists are increasingly aware of the need for absolute quantification of nucleic acids. To make their analyses actionable, scientists want to directly ...
Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...
Industry’s First 6-Color Digital PCR System Answers Market Needs for Higher Performance and Multiplexing Technology BOSTON & PARIS--(BUSINESS WIRE)--Stilla Technologies, the multiplex digital PCR ...
Digital PCR (dPCR) is a powerful technology for detecting and quantifying nucleic acids. In dPCR, nucleic acids within a sample are randomly distributed into numerous small-volume micro-reactions and ...
an immersive virtual event dedicated to exploring the remarkable capabilities of digital PCR. This experience invites you to delve into the forefront of scientific innovation across diverse research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results